Dynavax Technologies



Ebit Zmiana Data
AbbVie USD 5.65B 407M 2025-03
Adma Biologics USD 37.59M 2.05M 2024-12
Amgen USD 3.6B 434M 2025-03
AstraZeneca USD 3.51B 1.3B 2025-06
Biogen USD 816.6M 233.8M 2025-06
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
Bristol-Myers Squibb USD 2.26B 1.92B 2025-06
Dynavax Technologies USD -23630000 22M 2025-03
Gilead Sciences USD 2.89B 221M 2025-03
Glaxosmithkline GBP 1.83B 1.76B 2024-12
Merck USD 6.36B 149M 2025-06
Neurocrine Biosciences USD 145.6M 121.9M 2025-06
Novartis USD -9190000000 13.87B 2025-06
Pfizer USD 5.93B 1.31B 2025-03
Regeneron Pharmaceuticals USD 913.7M 661M 2025-03
Roche Holding CHF 11.29B 2.68B 2024-06
Sarepta Therapeutics USD -300386000 462.07M 2025-03
TG Therapeutics USD 29.95M 17.52M 2024-12
Vertex Pharmaceuticals USD 1.2B 108.8M 2024-12


Dynavax Technologies - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.